Loading...

Lynda Diane Roman, MD

TitleAssociate Professor of Obstetrics & Gynecology
InstitutionUniversity of Southern California
DepartmentObstetrics & Gynecology
Phone+1 323 409 3405
vCardDownload vCard
    Other Positions
    TitleDivision Chief, Gynecologic Oncology
    InstitutionUniversity of Southern California

    TitleDirector, Gynecology Oncology Fellowship
    InstitutionUniversity of Southern California


    Collapse Overview 
    Collapse Overview
    Dr. Roman completed her fellowship in gynecologic oncology at the MD Anderson Cancer Center in Houston, Texas in 1991. Presently, she serves as Director of the Division of Gynecologic Oncology at the University of Southern California, as well as the Director of Research and the Fellowship Program Director. Also, Dr. Roman is the co-director of the Lynne Cohen Preventive Cancer Care Clinic at the USC/Norris Cancer Center. she has recently been appointed to the governing council of the Society of Gynecologic Oncologists.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Matsuo K, Purushotham S, Jiang B, Mandelbaum RS, Takiuchi T, Liu Y, Roman LD. Survival outcome prediction in cervical cancer: Cox models versus deep-learning model. Am J Obstet Gynecol. 2018 Dec 21. PMID: 30582927.
      View in: PubMed
    2. Matsuo K, Machida H, Mandelbaum RS, Mikami M, Enomoto T, Roman LD, Wright JD. Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States. J Gynecol Oncol. 2018 Nov; 29(6):e85. PMID: 30207094.
      View in: PubMed
    3. Matsuo K, Mandelbaum RS, Machida H, Purushotham S, Grubbs BH, Roman LD, Wright JD. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix. J Gynecol Oncol. 2018 Nov; 29(6):e91. PMID: 30207099.
      View in: PubMed
    4. Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD. Clinical utility of CA-125 in the management of uterine carcinosarcoma. J Gynecol Oncol. 2018 Nov; 29(6):e88. PMID: 30207096.
      View in: PubMed
    5. Brunette LL, Mhawech-Fauceglia PY, Ji L, Skeate JG, Brand HE, Lawrenson K, Walia S, Chiriva-Internati M, Groshen S, Roman LD, Kast WM, Da Silva DM. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. BMC Cancer. 2018 Oct 11; 18(1):970. PMID: 30309325.
      View in: PubMed
    6. Matsuo K, Machida H, Mandelbaum RS, Ragab OM, Roman LD, Wright JD. Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer. Gynecol Oncol. 2018 Sep 06. PMID: 30197062.
      View in: PubMed
    7. Brunette LL, Bonyadlou S, Ji L, Groshen S, Shuster D, Mehta A, Sposto R, Matsuo K, Lin YG, Roman LD. Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer. Clin Nucl Med. 2018 Aug 27. PMID: 30153151.
      View in: PubMed
    8. Machida H, Mandelbaum RS, Mikami M, Enomoto T, Sonoda Y, Grubbs BH, Paulson RJ, Roman LD, Wright JD, Matsuo K. Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy versus hysterectomy. Am J Obstet Gynecol. 2018 Aug 20. PMID: 30138618.
      View in: PubMed
    9. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD. Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma. Ann Surg Oncol. 2018 Aug 13. PMID: 30105438.
      View in: PubMed
    10. Matsuo K, Blake EA, Machida H, Mandelbaum RS, Roman LD, Wright JD. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis. Gynecol Oncol. 2018 Jul 24. PMID: 30054103.
      View in: PubMed
    11. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma. Ann Surg Oncol. 2018 Jul 03. PMID: 29971677.
      View in: PubMed
    12. Matsuo K, Spragg SE, Ciccone MA, Blake EA, Ricker C, Pham HQ, Roman LD. Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series. Gynecol Oncol Rep. 2018 Aug; 25:98-101. PMID: 29998185.
      View in: PubMed
    13. Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman LD, Wright JD. Trends and outcomes of women with synchronous endometrial and ovarian cancer. Oncotarget. 2018 Jun 19; 9(47):28757-28771. PMID: 29983894.
      View in: PubMed
    14. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD. Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element. Surg Oncol. 2018 Sep; 27(3):433-440. PMID: 30217299.
      View in: PubMed
    15. Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. J Gynecol Oncol. 2018 May 04. PMID: 30022633.
      View in: PubMed
    16. Matsuo K, Yabuno A, Hom MS, Shida M, Kakuda M, Adachi S, Mandelbaum RS, Ueda Y, Hasegawa K, Enomoto T, Mikami M, Roman LD. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer. Gynecol Oncol. 2018 Mar 12. PMID: 29605499.
      View in: PubMed
    17. Matei D, Ghamande S, Roman L, Alvarez Secord A, Nemunaitis J, Markham MJ, Nephew KP, Jueliger S, Oganesian A, Naim S, Su XY, Keer H, Azab M, Fleming GF. A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. Clin Cancer Res. 2018 May 15; 24(10):2285-2293. PMID: 29500276.
      View in: PubMed
    18. Matsuo K, Tanabe K, Ikeda M, Shibata T, Kajiwara H, Miyazawa M, Miyazawa M, Hayashi M, Shida M, Hirasawa T, Roman LD, Mikami M. Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma. Arch Gynecol Obstet. 2018 Mar; 297(3):749-756. PMID: 29340789.
      View in: PubMed
    19. Matsuo K, Ross MS, Machida H, Blake EA, Roman LD. Trends of uterine carcinosarcoma in the United States. J Gynecol Oncol. 2018 Mar; 29(2):e22. PMID: 29400015.
      View in: PubMed
    20. Machida H, Blake EA, Eckhardt SE, Takiuchi T, Grubbs BH, Mikami M, Roman LD, Matsuo K. Trends in single women with malignancy of the uterine cervix in United States. J Gynecol Oncol. 2018 Mar; 29(2):e24. PMID: 29400017.
      View in: PubMed
    21. Matsuo K, Ross MS, Im DD, Klobocista MM, Bush SH, Johnson MS, Takano T, Blake EA, Ikeda Y, Nishimura M, Ueda Y, Shida M, Hasegawa K, Baba T, Adachi S, Yokoyama T, Satoh S, Machida H, Yanai S, Iwasaki K, Miyake TM, Takeuchi S, Takekuma M, Nagano T, Yunokawa M, Pejovic T, Omatsu K, Shahzad MMK, Kelley JL, Ueland FR, Roman LD. Significance of venous thromboembolism in women with uterine carcinosarcoma. Gynecol Oncol. 2018 Feb; 148(2):267-274. PMID: 29248197.
      View in: PubMed
    22. Matsuo K, Roman LD, Wright JD. Reply. Am J Obstet Gynecol. 2018 Feb; 218(2):264. PMID: 29061361.
      View in: PubMed
    23. Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MMK, Ueland FR, Kelley JL, Roman LD. Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma. Gynecol Oncol. 2017 12; 147(3):565-571. PMID: 29056442.
      View in: PubMed
    24. Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Klobocista MM, Hasegawa K, Ueda Y, Shida M, Baba T, Satoh S, Yokoyama T, Machida H, Ikeda Y, Adachi S, Miyake TM, Iwasaki K, Yanai S, Takeuchi S, Nishimura M, Nagano T, Takekuma M, Shahzad MMK, Pejovic T, Omatsu K, Kelley JL, Ueland FR, Roman LD. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. J Surg Oncol. 2017 Oct 16. PMID: 29044542.
      View in: PubMed
    25. Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman LD, Wright JD. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Gynecol Oncol. 2017 12; 147(3):558-564. PMID: 28986093.
      View in: PubMed
    26. Machida H, Eckhardt SE, Castaneda AV, Blake EA, Pham HQ, Roman LD, Matsuo K. Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States. Int J Gynecol Cancer. 2017 10; 27(8):1737-1746. PMID: 28704326.
      View in: PubMed
    27. Matsuo K, Purushotham S, Moeini A, Li G, Machida H, Liu Y, Roman LD. A pilot study in using deep learning to predict limited life expectancy in women with recurrent cervical cancer. Am J Obstet Gynecol. 2017 12; 217(6):703-705. PMID: 28843741.
      View in: PubMed
    28. Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Saglam O, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman LD, Sood AK, Gershenson DM. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol. 2018 Feb; 117(2):236-244. PMID: 28787528.
      View in: PubMed
    29. Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer. Obstet Gynecol. 2017 Aug; 130(2):403-410. PMID: 28697110.
      View in: PubMed
    30. Machida H, Moeini A, Ciccone MA, Mostofizadeh S, Takiuchi T, Brunette LL, Roman LD, Matsuo K. Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer. Am J Clin Oncol. 2017 Jul 31. PMID: 28763329.
      View in: PubMed
    31. Matsuo K, Machida H, Horowitz MP, Shahzad MMK, Guntupalli SR, Roman LD, Wright JD. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer. Am J Obstet Gynecol. 2017 11; 217(5):580.e1-580.e10. PMID: 28666700.
      View in: PubMed
    32. Matsuo K, Machida H, Ragab OM, Garcia-Sayre J, Yessaian AA, Roman LD. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer. J Surg Oncol. 2017 Sep; 116(4):482-491. PMID: 28543055.
      View in: PubMed
    33. Machida H, Maeda M, Cahoon SS, Scannell CA, Garcia-Sayre J, Roman LD, Matsuo K. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities? Arch Gynecol Obstet. 2017 Jun; 295(6):1459-1468. PMID: 28444512.
      View in: PubMed
    34. Matsuo K, Machida H, Takiuchi T, Garcia-Sayre J, Yessaian AA, Roman LD. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy. Gynecol Oncol. 2017 Apr; 145(1):41-49. PMID: 28215841.
      View in: PubMed
    35. Matsuo K, Omatsu K, Ross MS, Johnson MS, Yunokawa M, Klobocista MM, Im DD, Bush SH, Ueda Y, Takano T, Blake EA, Hasegawa K, Baba T, Shida M, Satoh S, Yokoyama T, Machida H, Adachi S, Ikeda Y, Iwasaki K, Miyake TM, Yanai S, Nishimura M, Nagano T, Takekuma M, Takeuchi S, Pejovic T, Shahzad MM, Ueland FR, Kelley JL, Roman LD. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma. Gynecol Oncol. 2017 04; 145(1):78-87. PMID: 28215838.
      View in: PubMed
    36. Matsuo K, Machida H, Takiuchi T, Grubbs BH, Roman LD, Sood AK, Gershenson DM. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors. Gynecol Oncol. 2017 03; 144(3):496-502. PMID: 28131526.
      View in: PubMed
    37. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol. 2017 01; 129(1):139-151. PMID: 27926642.
      View in: PubMed
    38. Matsuo K, Machida H, Ragab OM, Takiuchi T, Pham HQ, Roman LD. Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer. Gynecol Oncol. 2017 03; 144(3):515-523. PMID: 28017306.
      View in: PubMed
    39. Matsuo K, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Ueda Y, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Takeuchi S, Nishimura M, Iwasaki K, Yanai S, Klobocista MM, Johnson MS, Machida H, Hasegawa K, Miyake TM, Nagano T, Pejovic T, Shahzad MM, Im DD, Omatsu K, Ueland FR, Kelley JL, Roman LD. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma. Gynecol Oncol. 2017 Feb; 144(2):329-335. PMID: 27931750.
      View in: PubMed
    40. Tierney KE, Ji L, Dralla SS, Yoo E, Yessaian A, Pham HQ, Roman L, Sposto R, Mhawech-Fauceglia P, Lin YG. Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. Gynecol Oncol. 2016 Dec; 143(3):650-654. PMID: 27771165.
      View in: PubMed
    41. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer. Obstet Gynecol. 2016 10; 128(4):761-70. PMID: 27607873.
      View in: PubMed
    42. Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA, Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu AH, Pike MC, Stram DO, Pearce CL. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. Int J Cancer. 2016 Dec 15; 139(12):2646-2654. PMID: 27420401.
      View in: PubMed
    43. Matsuo K, Cahoon SS, Yoshihara K, Shida M, Kakuda M, Adachi S, Moeini A, Machida H, Garcia-Sayre J, Ueda Y, Enomoto T, Mikami M, Roman LD, Sood AK. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer. Obstet Gynecol. 2016 Jul; 128(1):127-37. PMID: 27275802.
      View in: PubMed
    44. Matsuo K, Moeini A, Machida H, Fullerton ME, Shabalova A, Brunette LL, Roman LD. Significance of venous thromboembolism in women with cervical cancer. Gynecol Oncol. 2016 09; 142(3):405-12. PMID: 27350404.
      View in: PubMed
    45. Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A, Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ, Wu AH, Pike MC, Pearce CL. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol. 2016 05; 127(5):828-36. PMID: 27054934; PMCID: PMC4892111 [Available on 05/01/17].
    46. Matsuo K, Gualtieri MR, Cahoon SS, Toboni MD, Machida H, Moeini A, Hasegawa K, Shoupe D, Roman LD. Contributing factors for menopausal symptoms after surgical staging for endometrial cancer. Menopause. 2016 05; 23(5):535-43. PMID: 26757269.
      View in: PubMed
    47. Matsuo K, Jung CE, Hom MS, Gualtieri MR, Randazzo SC, Kanao H, Yessaian AA, Roman LD. Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer. Int J Gynecol Cancer. 2016 Feb; 26(2):290-300. PMID: 26569058.
      View in: PubMed
    48. Matsuo K, Gualtieri MR, Cahoon SS, Jung CE, Paulson RJ, Shoupe D, Muderspach LI, Wakatsuki A, Wright JD, Roman LD. Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause. 2016 Feb; 23(2):189-96. PMID: 26173075.
      View in: PubMed
    49. Matsuo K, Moeini A, Machida H, Scannell CA, Casabar JK, Kakuda M, Adachi S, Garcia-Sayre J, Ueda Y, Roman LD. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis. Ann Surg Oncol. 2016 Mar; 23(3):959-67. PMID: 26542589.
      View in: PubMed
    50. Machida H, Casey JP, Garcia-Sayre J, Jung CE, Casabar JK, Moeini A, Kato K, Roman LD, Matsuo K. Timing of Intrauterine Manipulator Insertion During Minimally Invasive Surgical Staging and Results of Pelvic Cytology in Endometrial Cancer. J Minim Invasive Gynecol. 2016 Feb 01; 23(2):234-41. PMID: 26475765.
      View in: PubMed
    51. Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman LD. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. J Surg Oncol. 2015 Nov; 112(6):669-76. PMID: 26391212.
      View in: PubMed
    52. Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman LD, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol. 2015 Dec; 161(2):197-208. PMID: 26360252; PMCID: PMC4658296 [Available on 12/01/16].
    53. Matsuo K, Ramzan AA, Gualtieri MR, Mhawech-Fauceglia P, Machida H, Moeini A, Dancz CE, Ueda Y, Roman LD. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015 Nov; 139(2):261-7. PMID: 26238457.
      View in: PubMed
    54. Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman LD, Gabra H, Fotopoulou C, Sood AK. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. Eur J Cancer. 2015 Sep; 51(14):1978-88. PMID: 26238017.
      View in: PubMed
    55. Machida H, Moeini A, Roman LD, Matsuo K. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecol Oncol. 2015 Oct; 139(1):165-71. PMID: 26193428.
      View in: PubMed
    56. Lawrenson K, Pakzamir E, Liu B, Lee JM, Delgado MK, Duncan K, Gayther SA, Liu S, Roman L, Mhawech-Fauceglia P. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium. PLoS One. 2015; 10(7):e0130909. PMID: 26132201; PMCID: PMC4488511.
    57. Matsuo K, Tierney KE, Schneider DM, Mhawech-Fauceglia P, Roman LD, Gershenson DM. Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series. Gynecol Oncol Rep. 2015 Aug; 13:36-9. PMID: 26425718; PMCID: PMC4563586.
    58. Matsuo K, Opper NR, Roman LD. In reply. Obstet Gynecol. 2015 Jun; 125(6):1498. PMID: 26000531.
      View in: PubMed
    59. Matsuo K, Hom MS, Moeini A, Machida H, Takeshima N, Roman LD, Sood AK. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer. Gynecol Oncol. 2015 Aug; 138(2):332-8. PMID: 26013698.
      View in: PubMed
    60. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman LD. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015 Feb; 125(2):424-33. PMID: 25569000.
      View in: PubMed
    61. Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, Wu AH, Berchuck A, Pike MC, Pharoah PDP. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):671-676. PMID: 25623732; PMCID: PMC4892114.
    62. Wu E, Rogers A, Ji L, Sposto R, Church T, Roman L, Tripathy D, Lin YG. Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract. 2015 Mar; 11(2):e163-9. PMID: 25604595; PMCID: PMC4371122.
    63. Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman LD, Sood AK. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion. Gynecol Oncol. 2015 Feb; 136(2):198-204. PMID: 25497604.
      View in: PubMed
    64. Piatek CI, Raja GL, Ji L, Gitlitz BJ, Dorff TB, Quinn DI, Hu J, El-Khoueiry AB, Pham HQ, Roman L, Garcia AA. Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors. Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. PMID: 25374407.
      View in: PubMed
    65. Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, Paulson RJ, Muderspach LI, Roman LD. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. Ann Surg Oncol. 2014 Dec; 21(13):4246-55. PMID: 25001096.
      View in: PubMed
    66. Matsuo K, Yoshino K, Hiramatsu K, Banzai C, Hasegawa K, Yasuda M, Nishimura M, Sheridan TB, Ikeda Y, Shiki Y, Mabuchi S, Enomoto T, Kimura T, Fujiwara K, Roman LD, Sood AK. Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer. Obstet Gynecol. 2014 May; 123(5):957-65. PMID: 24785846; PMCID: PMC4174541.
    67. Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman LD, Sood AK. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma. Gynecol Oncol. 2014 Jun; 133(3):473-9. PMID: 24674832; PMCID: PMC4170217.
    68. Lentz SE, Tierney KE, Weaver FA, Roman LD. Abdominal aortic resection and Y-graft placement to achieve complete cytoreduction in stage IIIc ovarian carcinoma. Obstet Gynecol. 2014 Feb; 123(2 Pt 2 Suppl 2):486-8. PMID: 24413236.
      View in: PubMed
    69. Herzog TJ, Monk BJ, Rose PG, Braly P, Hines JF, Bell MC, Wenham RM, Secord AA, Roman LD, Einstein MH, Drake RD, Childs BH. A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Gynecol Oncol. 2014 Mar; 132(3):517-25. PMID: 24476788.
      View in: PubMed
    70. Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2014 Apr; 210(4):366.e1-366.e5. PMID: 24370689.
      View in: PubMed
    71. Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynecol Oncol. 2013 Oct; 131(1):109-12. PMID: 23917081.
      View in: PubMed
    72. Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6. PMID: 23718934.
      View in: PubMed
    73. Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman LD. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013 Mar; 128(3):544-51. PMID: 23262205.
      View in: PubMed
    74. Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman LD. Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med. 2012 Oct; 1(2):156-64. PMID: 23342265; PMCID: PMC3544453.
    75. Matsuo K, Fleischman F, Ghattas CS, Gabrielyan AS, Ballard CA, Roman LD, Morrow CP. Successful extraction of cardiac-extending intravenous leiomyomatosis through gonadal vein. Fertil Steril. 2012 Nov; 98(5):1341-5.e1. PMID: 22902061.
      View in: PubMed
    76. Garcia AA, Yessaian A, Pham H, Facio G, Muderspach L, Roman L. Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer. Cancer Invest. 2012 May; 30(4):295-9. PMID: 22468744.
      View in: PubMed
    77. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, Im DD, Rosenshein NB, Roman LD. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012 Feb; 22(2):245-53. PMID: 22228425.
      View in: PubMed
    78. Matsuo K, Blake EA, Yessaian AA, Roman LD. Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer. Oncologist. 2012; 17(12):1598-9. PMID: 23263923; PMCID: PMC3528394.
    79. Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman LD, Berchuck A, Pearce CL, Laird PW. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011; 6(12):e28141. PMID: 22163280; PMCID: PMC3233546.
    80. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov; 116(5):1150-7. PMID: 20966701.
      View in: PubMed
    81. Matsuo K, Lin YG, Roman LD, Sood AK. Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs. 2010 Nov; 19(11):1339-54. PMID: 20815774; PMCID: PMC2962713.
    82. Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2009 Mar 01; 27(7):1069-74. PMID: 19139430; PMCID: PMC2667811.
    83. Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res. 2008 Nov 15; 14(22):7554-63. PMID: 19010874; PMCID: PMC2586993.
    84. Garcia AA, Hirte H, Fleming G, Yang D, Tsao-Wei DD, Roman L, Groshen S, Swenson S, Markland F, Gandara D, Scudder S, Morgan R, Chen H, Lenz HJ, Oza AM. Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. J Clin Oncol. 2008 Jan 01; 26(1):76-82. PMID: 18165643.
      View in: PubMed
    85. Garcia AA, Blessing JA, Vaccarello L, Roman LD. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Am J Clin Oncol. 2007 Aug; 30(4):428-31. PMID: 17762444.
      View in: PubMed
    86. Brinkman JA, Hughes SH, Stone P, Caffrey AS, Muderspach LI, Roman LD, Weber JS, Kast WM. Therapeutic vaccination for HPV induced cervical cancers. Dis Markers. 2007; 23(4):337-52. PMID: 17627067; PMCID: PMC3851105.
    87. Lowe MP, Bahador A, Muderspach LI, Burnett A, Santos L, Caffrey A, Roman LD, Morrow CP. Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program. J Minim Invasive Gynecol. 2006 Sep-Oct; 13(5):391-7. PMID: 16962520.
      View in: PubMed
    88. Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10; 24(26):4324-32. PMID: 16896006.
      View in: PubMed
    89. Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman LD. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 2006 Feb; 100(2):288-93. PMID: 16182347.
      View in: PubMed
    90. Roman LD. Pregnancy after radical vaginal trachelectomy: maybe not such a risky undertaking after all. Gynecol Oncol. 2005 Jul; 98(1):1-2. PMID: 15946730.
      View in: PubMed
    91. Mateo R, Singh G, Jabbour N, Palmer S, Genyk Y, Roman L. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecol Oncol. 2005 Apr; 97(1):266-70. PMID: 15790474.
      View in: PubMed
    92. Garcia AA, Roman L, Muderspach L, O'meara A, Facio G, Edwards S, Burnett A. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. Cancer Invest. 2005; 23(8):665-70. PMID: 16377584.
      View in: PubMed
    93. Burnett AF, O'Meara AT, Bahador A, Roman LD, Morrow CP. Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience. Gynecol Oncol. 2004 Oct; 95(1):189-92. PMID: 15385130.
      View in: PubMed
    94. Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2004 May; 93(2):493-8. PMID: 15099968.
      View in: PubMed
    95. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau L. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res. 2004 Apr 15; 10(8):2681-6. PMID: 15102671.
      View in: PubMed
    96. Burnett AF, Roman LD, O'Meara AT, Morrow CP. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol Oncol. 2003 Mar; 88(3):419-23. PMID: 12648596.
      View in: PubMed